• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Self-reactive T cells: suppressing the suppressors.自身反应性 T 细胞:抑制抑制物。
Cancer Immunol Immunother. 2014 Apr;63(4):313-9. doi: 10.1007/s00262-013-1512-9. Epub 2013 Dec 25.
2
Advantage of having regulatory T cells requires localized suppression of immune reactions.拥有调节性 T 细胞的优势需要局部抑制免疫反应。
J Theor Biol. 2009 Oct 7;260(3):392-401. doi: 10.1016/j.jtbi.2009.06.020. Epub 2009 Jun 27.
3
CD4+ T Cell Tolerance to Tissue-Restricted Self Antigens Is Mediated by Antigen-Specific Regulatory T Cells Rather Than Deletion.CD4 + T细胞对组织限制性自身抗原的耐受性由抗原特异性调节性T细胞介导,而非通过细胞缺失。
Immunity. 2015 Nov 17;43(5):896-908. doi: 10.1016/j.immuni.2015.10.011. Epub 2015 Nov 10.
4
Potential roles of self-reactive T cells in autoimmunity: lessons from cancer immunology.自身反应性T细胞在自身免疫中的潜在作用:来自癌症免疫学的启示。
Immunol Res. 2014 Dec;60(2-3):156-64. doi: 10.1007/s12026-014-8559-3.
5
PDCD5 negatively regulates autoimmunity by upregulating FOXP3(+) regulatory T cells and suppressing Th17 and Th1 responses.PDCD5 通过上调 FOXP3(+)调节性 T 细胞和抑制 Th17 和 Th1 反应来负调控自身免疫。
J Autoimmun. 2013 Dec;47:34-44. doi: 10.1016/j.jaut.2013.08.002. Epub 2013 Sep 5.
6
Self-reactive T cell receptor-reactive CD8+ T cells inhibit T cell lymphoma growth in vivo.自身反应性T细胞受体反应性CD8 + T细胞在体内抑制T细胞淋巴瘤生长。
J Immunol. 2004 Dec 1;173(11):7062-9. doi: 10.4049/jimmunol.173.11.7062.
7
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model.同时抑制两种调节性 T 细胞亚群可增强白细胞介素-15 在前列腺肿瘤模型中的疗效。
Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):6187-92. doi: 10.1073/pnas.1203479109. Epub 2012 Apr 2.
8
TNF activates a NF-kappaB-regulated cellular program in human CD45RA- regulatory T cells that modulates their suppressive function.TNF 激活人 CD45RA-调节性 T 细胞中 NF-κB 调节的细胞程序,调节其抑制功能。
J Immunol. 2010 Apr 1;184(7):3570-81. doi: 10.4049/jimmunol.0902070. Epub 2010 Feb 24.
9
Antigen-induced regulatory T cells in autoimmunity.自身免疫中抗原诱导的调节性T细胞。
Nat Rev Immunol. 2003 Mar;3(3):223-32. doi: 10.1038/nri1029.
10
Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity.调节性T细胞中Foxo1活性的分级可区分肿瘤免疫与自发性自身免疫。
Nature. 2016 Jan 28;529(7587):532-6. doi: 10.1038/nature16486. Epub 2016 Jan 20.

引用本文的文献

1
Current understanding of the human microbiome in glioma.当前对胶质瘤中人类微生物组的认识。
Front Oncol. 2022 Aug 8;12:781741. doi: 10.3389/fonc.2022.781741. eCollection 2022.
2
The Gut-Brain Axis, Paving the Way to Brain Cancer.肠-脑轴:通向脑癌之路
Trends Cancer. 2019 Apr;5(4):200-207. doi: 10.1016/j.trecan.2019.02.008. Epub 2019 Mar 16.
3
PD-L1-specific T cells.程序性死亡配体1特异性T细胞
Cancer Immunol Immunother. 2016 Jul;65(7):797-804. doi: 10.1007/s00262-015-1783-4. Epub 2016 Jan 2.
4
Pre-Vaccination Frequencies of Th17 Cells Correlate with Vaccine-Induced T-Cell Responses to Survivin-Derived Peptide Epitopes.接种疫苗前Th17细胞的频率与疫苗诱导的针对生存素衍生肽表位的T细胞反应相关。
PLoS One. 2015 Jul 15;10(7):e0131934. doi: 10.1371/journal.pone.0131934. eCollection 2015.
5
Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancer.色氨酸 2,3-双加氧酶(TDO)反应性 T 细胞在健康和癌症中的功能特征不同。
Oncoimmunology. 2015 Jan 30;4(1):e968480. doi: 10.4161/21624011.2014.968480. eCollection 2015 Jan.
6
IDO2 in Immunomodulation and Autoimmune Disease.吲哚胺 2,3-双加氧酶 2 在免疫调节与自身免疫性疾病中的作用
Front Immunol. 2014 Nov 20;5:585. doi: 10.3389/fimmu.2014.00585. eCollection 2014.
7
Introduction to the special issue on the 9th International Congress on Autoimmunity.第九届国际自身免疫大会特刊引言
Immunol Res. 2014 Dec;60(2-3):153-5. doi: 10.1007/s12026-014-8605-1.

本文引用的文献

1
Functional characterization of Foxp3-specific spontaneous immune responses.Foxp3 特异性自发免疫反应的功能特征。
Leukemia. 2013 Dec;27(12):2332-40. doi: 10.1038/leu.2013.196. Epub 2013 Jul 1.
2
The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4 T cells.免疫检查点调节剂PD-L1是天然存在的CD4 T细胞的特异性靶点。
Oncoimmunology. 2013 Apr 1;2(4):e23991. doi: 10.4161/onci.23991.
3
Cutaneous T cell lymphoma cells are targets for immune checkpoint ligand PD-L1-specific, cytotoxic T cells.皮肤T细胞淋巴瘤细胞是免疫检查点配体PD-L1特异性细胞毒性T细胞的靶标。
Leukemia. 2013 Nov;27(11):2251-3. doi: 10.1038/leu.2013.118. Epub 2013 Apr 18.
4
Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.髓源性抑制细胞通过 IDO 表达抑制抗肿瘤免疫反应,并与乳腺癌患者的淋巴结转移相关。
J Immunol. 2013 Apr 1;190(7):3783-97. doi: 10.4049/jimmunol.1201449. Epub 2013 Feb 25.
5
HLA-restricted CTL that are specific for the immune checkpoint ligand PD-L1 occur with high frequency in cancer patients.在癌症患者中,高频率出现针对免疫检查点配体 PD-L1 的 HLA 限制 CTL。
Cancer Res. 2013 Mar 15;73(6):1764-76. doi: 10.1158/0008-5472.CAN-12-3507. Epub 2013 Jan 17.
6
Cyclophosphamide promotes chronic inflammation-dependent immunosuppression and prevents antitumor response in melanoma.环磷酰胺促进慢性炎症依赖性免疫抑制,防止黑色素瘤的抗肿瘤反应。
J Invest Dermatol. 2013 Jun;133(6):1610-9. doi: 10.1038/jid.2012.444. Epub 2012 Dec 6.
7
IDO is a nodal pathogenic driver of lung cancer and metastasis development.IDO 是肺癌及转移发展的一个关键性的致瘤驱动因素。
Cancer Discov. 2012 Aug;2(8):722-35. doi: 10.1158/2159-8290.CD-12-0014. Epub 2012 Jul 19.
8
Programmed elimination of cells by caspase-independent cell extrusion in C. elegans.通过 caspase 非依赖性细胞挤出程序性消除线虫细胞。
Nature. 2012 Aug 9;488(7410):226-30. doi: 10.1038/nature11240.
9
Regulatory T-cell modulation using cyclophosphamide in vaccine approaches: a current perspective.使用环磷酰胺调节调节性 T 细胞在疫苗方法中的应用:当前的观点。
Cancer Res. 2012 Jul 15;72(14):3439-44. doi: 10.1158/0008-5472.CAN-11-3912. Epub 2012 Jul 3.
10
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.抗 PD-L1 抗体在晚期癌症患者中的安全性和活性。
N Engl J Med. 2012 Jun 28;366(26):2455-65. doi: 10.1056/NEJMoa1200694. Epub 2012 Jun 2.

自身反应性 T 细胞:抑制抑制物。

Self-reactive T cells: suppressing the suppressors.

机构信息

Department of General Dermatology, Medical University of Graz, Graz, Austria.

出版信息

Cancer Immunol Immunother. 2014 Apr;63(4):313-9. doi: 10.1007/s00262-013-1512-9. Epub 2013 Dec 25.

DOI:10.1007/s00262-013-1512-9
PMID:24368340
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11029163/
Abstract

The immune system is a tightly regulated and complex system. An important part of this immune regulation is the assurance of tolerance toward self-antigens to maintain immune homeostasis. However, in recent years, antigen-specific cellular immune responses toward several normal self-proteins expressed in regulatory immune cells have been reported, especially in patients with cancer. The seemingly lack of tolerance toward such proteins is interesting, as it suggests a regulatory function of self-reactive T (srT) cells, which may be important for the fine tuning of the immune system. In particular, surprising has been the description of cytotoxic srT cells that are able to eliminate normal regulatory immune cells. Such srT cells may be important as effector cells that suppress regulatory suppressor cells. The current knowledge of the nature and function of srT cells is still limited. Still, the therapeutic targeting of srT cells offers a novel approach to harness immune-regulatory networks in cancer.

摘要

免疫系统是一个高度调节和复杂的系统。这种免疫调节的一个重要部分是确保对自身抗原的耐受性,以维持免疫平衡。然而,近年来,人们已经报道了针对调节性免疫细胞中几种正常自身蛋白的抗原特异性细胞免疫反应,尤其是在癌症患者中。这种对这些蛋白似乎缺乏耐受性的现象很有趣,因为它提示了自身反应性 T(srT)细胞的调节功能,这可能对免疫系统的精细调节很重要。特别是,令人惊讶的是描述了能够消除正常调节性免疫细胞的细胞毒性 srT 细胞。这些 srT 细胞可能是作为抑制调节性抑制细胞的效应细胞很重要。目前对 srT 细胞的性质和功能的了解仍然有限。尽管如此,srT 细胞的治疗靶向为利用癌症中的免疫调节网络提供了一种新方法。